Colossal Biosciences
Last verified 2026-05-19. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $567.7Mattributed |
|---|---|
| Latest round | series-c, $200.0M, 2025-01-15attributed |
| Founded | 2021 |
| Headquarters | Austin, USA |
| Industry | bio |
| Stage | series-b+ |
| Website | colossal.com |
Colossal is a genetics and biosciences company using gene editing to restore extinct species and protect threatened wildlife. It serves researchers, conservationists, and organizations addressing biodiversity loss. De-extinction rebuilds DNA of lost megafauna with measurable ecological roles, rather than only protecting what remains.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-01-15 | series-c | $200.0M | undisclosed |
Detected tech stack
Cloudflare, WordPress, Google Analytics, Google Tag Manager, Gravity Forms 2.10.2, GSAP, Slick, jsDelivr, Popper, Drift, Cloudflare Bot Management, WP Engine
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series C, $200.0M | attributed | techcrunch named as publisher. No document URL on file. |
| Total raised $567.7M | attributed | techcrunch named as publisher. No document URL on file. |
| Company existence | self-reported | colossal.com, read 2026-05-19 |
| Description | self-reported | colossal.com, read 2026-05-19 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.